Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

An experimental study of anti-angiogenesis with recombinant human kringle 5.

An experimental study of anti-angiogenesis with recombinant human kringle 5. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • An experimental study of anti-angiogenesis with recombinant human kringle 5. Abstract Text:

    zuguo liuZuguo Liu,zhihong zhangZhihong Zhang,jianxing maJianxing Ma,mei zhangMei Zhang,lihui luoLihui Luo,qiguo xiaoQiguo Xiao,jianxian linJianxian Lin,ping zhangPing Zhang,jiaqi chenJiaqi Chen,

    OBJECTIVE: To investigate the anti-angiogenesis effects of recombinant human kringle 5 (rhk5) eye drops on corneal neovascularization (CNV) in rabbits induced by alkali burn. METHODS: Forty New Zealand albino rabbits were burned on the central corneas of their right eyes by 1 mol/L NaOH for 60s. Animals were randomly divided into 4 groups, 10 rabbits each group. Then rhk5 eye drops with different concentrations were applied four times daily for four weeks on each group: 5 mg/L in group 1, 10 mg/L in group 2, 20 mg/L in group 3 and carrier solution in group 4 (controls). The occurrence and development of CNV was observed every other day by slit-lamp microscope, and the area of CNV was calculated. Then the rabbits were killed on the 28th day (d), and the corneas were taken for histopathological examinations. Pearson's analysis was used to analyze the correlation between the number of inflammatory cells and the area of CNV. RESULTS: The occurrence of CNV in group 1 was (3.4 +/- 0.5) d, group 2 (6.8 +/- 0.4) d, group 3 (6.7 +/- 0.7) d and group 4 (3.7 +/- 0.5) d. Significant difference (P < 0.05) in the occurrence time of CNV was found between group 2 and the control. Compared with the control group, the CNV occurrence was significantly delayed in the group treated by 10 mg/L rhk5. No significant difference was found between control group and group 1, and between group 2 and group 3. The CNV areas of group 2 and group 3 were also smaller than the control group (P < 0.05). The area of CNV had close relationship with the retrocorneal membrane and with the number of inflammatory cells (P < 0.05). CONCLUSION: Topical application of recombinant human rhk5 has prominent effectiveness on the inhibition of angiogenesis induced by alkali burn.

    An experimental study of anti-angiogenesis with recombinant human kringle 5. Publishing Authors By Initials

    z liuZ Liu,z zhangZ Zhang,j maJ Ma,m zhangM Zhang,l luoL Luo,q xiaoQ Xiao,j linJ Lin,p zhangP Zhang,j chenJ Chen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    An experimental study of anti-angiogenesis with recombinant human kringle 5. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: [Zhonghua yan ke za zhi] Chinese journal of ophtha

    VOLUME: 38

    Page Numbers: 415-8

    Journal Abbreviation: Zhonghua Yan Ke Za Zhi

    ISSN: 0412-4081

    DAY: 4

    MONTH: Jul

    YEAR: 2002

    An experimental study of anti-angiogenesis with recombinant human kringle 5. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 16210540

    An experimental study of anti-angiogenesis with recombinant human kringle 5. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: An experimental study of anti-angiogenesis with recombinant human kringle 5. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for An experimental study of anti-angiogenesis with recombinant human kringle 5.

    AFFILIATION: Zhongshan Opthalmic Center, Sun Yat-sen University, Guangzhou 510060, China (Email: zuguol@yahoo.com)

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Zhonghua Yan Ke Za Zhi

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    An experimental study of anti-angiogenesis with recombinant human kringle 5 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News